P3 Health Partners Inc. (NASDAQ:PIII) Shares Shorted: Short Interest Down 50.4% in September

Posted by Stanley Muller on Oct 16th, 2026

P3 Health Partners Inc. (NASDAQ:PIII – Get Free Report) was the target of a large decline in short interest during the month of September. As of September 30th, there was short interest totaling 13,637 shares, a decline of 50.4% from the September 15th total of 27,498 shares. Approximately 0.2% of the shares of the company are sold short. Based on an average daily trading volume, of 10,090 shares, the short-interest ratio is presently 1.4 days.

P3 Health Partners Stock Performance

PIII stock remained flat at $4.14 during midday trading on Friday. 15,229 shares of the company’s stock were exchanged, compared to its average volume of 440,604. P3 Health Partners has a twelve month low of $1.52 and a twelve month high of $16.89. The company has a market cap of $30.06 million, a PE ratio of -0.13 and a beta of 1.70. The stock’s 50-day moving average is $8.27 and its 200-day moving average is $8.32.

P3 Health Partners (NASDAQ:PIII – Get Free Report) last issued its quarterly earnings results on Monday, August 10th. The company reported ($0.63) earnings per share for the quarter, topping the consensus estimate of ($1.89) by $1.26. The business had revenue of $386.38 million for the quarter, compared to analysts’ expectations of $377.80 million.

Insiders Place Their Bets

In other news, major shareholder Hudson Vegas Investment Spv, L sold 50,000 shares of the stock in a transaction on Monday, August 10th. The stock was sold at an average price of $16.48, for a total transaction of $824,000.00. Following the transaction, the insider directly owned 48,959 shares of the company’s stock, valued at $806,844.32. This represents a 50.53% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 10.86% of the company’s stock.

Institutional Trading of P3 Health Partners

A hedge fund recently bought a new position in P3 Health Partners stock. Diversified Trust Co purchased a new stake in shares of P3 Health Partners Inc. (NASDAQ:PIII – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 20,316 shares of the company’s stock, valued at approximately $63,000. Diversified Trust Co owned approximately 0.28% of P3 Health Partners at the end of the most recent reporting period. 7.75% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages recently commented on PIII. Lake Street Capital reaffirmed a “buy” rating and issued a $23.00 price objective on shares of P3 Health Partners in a report on Tuesday, August 11th. Weiss Ratings reissued a “sell (d-)” rating on shares of P3 Health Partners in a research report on Tuesday, August 25th. Finally, Wall Street Zen raised P3 Health Partners to a “hold” rating in a research report on Saturday, July 4th. One research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $17.00.

Read Our Latest Research Report on P3 Health Partners

About P3 Health Partners

(Get Free Report)

P3 Health Partners Inc is a physician-led healthcare organization focused on value-based care for older adults, particularly beneficiaries enrolled in Medicare Advantage plans. The company works with primary care physicians, health plans and other healthcare providers to coordinate services and improve patient outcomes while managing the overall cost of care.

P3 supports its network through primary care services, care coordination, clinical programs and technology-enabled population health management.